AlphaFold predicted structure
MASP2 · O00187

Mean pLDDT
89.4/ 100
Confident
686 residues
Confidence breakdown
- Very high(≥ 90)73%
- Confident(70–90)21%
- Low(50–70)2%
- Very low(< 50)4%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
MBL associated serine protease 2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalInfantile enterocolitis & monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalimmunodeficiency due to MASP-2 deficiency
amyotrophic lateral sclerosis
frontotemporal dementia with motor neuron disease
motor neuron disorder
COVID-19
complement deficiency
Increased total eosinophil count
atypical hemolytic-uremic syndrome
neurodegenerative disease
frontotemporal dementia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Mannan-binding lectin serine protease 2
Precursor of a serum protease that activates the lectin pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:11527969, PubMed:22691502). The lectin complement system is activated following association of lectins, such as MBL2, FCN1, FCN2 or FCN3, to carbohydrates on the pathogen surface (PubMed:22691502, PubMed:22966085). MASP2 is cleaved and activated by MASP1 in response to lectin-binding to pathogen carbohydrates (PubMed:10946292, PubMed:22949645, PubMed:22966085, PubMed:9087411). Can activate prothrombin to thrombin (PubMed:39924859)
MASP2 · O00187

Mean pLDDT
89.4/ 100
Confident
686 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0